Qiagen NV

QGEN

----

Open: --
High: --
Low: --
Prev. Close: --
Volume: --
Turnover: --
Avg Price: --
Bid/Ask Ratio: --
Amplitude: --
52wk High: --
Volume Ratio: --
Turnover Ratio: --

52wk Low: --
Float Mkt Cap: --
Market Cap: --
P/E^TTM: --
P/E^Dynamic: --
P/E^Static: --
EPS^TTM: --
EPS^Dynamic: --
EPS^Static: --
BVPS: --
P/B: --
Circulating Supply: --
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: --
Min lot size: --
Currency: --

Qiagen NV Analyst Rating

Forecast & Rating

Nov 5, 2026

Price forecast

$49.59-1.42%

Forecast & RatingHold

12analysts

Strong buy0.00%
Buy8.33%
Hold91.67%
Sell0.00%
Strong sell0.00%

News

Posts

Bullish vs. Bearish — Last 3 Months

100 followers · 0 opinions

▲Bullish50%

50%Bearish▼

H
Hardik ShahMay 19, 2026 at 08:07 PM
📢 𝐉𝐔𝐒𝐓 𝐈𝐍: QIAGEN Partners With NVIDIA to Advance AI-Driven Drug Discovery - $Qiagen NV(QGEN.US) $NVIDIA(NVDA.US)
👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:
➤ QIAGEN collaborates with 𝐍𝐕𝐈𝐃𝐈𝐀 to integrate AI into bioinformatics workflows.
➤ Partnership combines QIAGEN biomedical databases with 𝐍𝐕𝐈𝐃𝐈𝐀 𝐁𝐢𝐨𝐍𝐞𝐌𝐨 platform.
➤ Focus on identifying 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐦𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬, biomarkers, and therapeutic targets.
➤ Integration applies 𝐠𝐫𝐚𝐩𝐡-𝐛𝐚𝐬𝐞𝐝 𝐀𝐈 to complex biological datasets.
➤ Supports drug discovery use cases including 𝐝𝐫𝐮𝐠 𝐫𝐞𝐩𝐮𝐫𝐩𝐨𝐬𝐢𝐧𝐠 and pathway analysis.
➤ QIAGEN knowledge bases currently serve 𝟏𝟓𝟎,𝟎𝟎𝟎+ scientists globally.
➤ Initial pilot programs launching with select 𝐩𝐡𝐚𝐫𝐦𝐚 and biotech partners.